Almost all human gastric mucin O-glycans harbor blood group A, B or H antigens and are potential binding sites for Helicobacter pylori

Glycobiology

Volumn 22, Issue 9, 2012, Pages 1193-1206

  Rossez, Yannick ^a,b   Maes, Emmanuel ^a,b   Lefebvre Darroman, Tony ^a,b   Gosset, Pierre ^a,c   Ecobichon, Chantal ^d,e   Joncquel Chevalier Curt, Marie ^a,b   Boneca, Ivo G ^d,e   Michalski, Jean Claude ^a,b   Robbe Masselot, Catherine ^a,b  

^a UNIV LILLE   (France)

^b UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^c UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

^d INSTITUT PASTEUR   (France)

^e INSERM   (France)

Author keywords

gastric mucins; glycosylation; human; mass spectrometry; NMR

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; BLOOD GROUP H ANTIGEN; EPITOPE; GLYCAN DERIVATIVE; OLIGOSACCHARIDE; STOMACH MUCIN;

ARTICLE; BINDING SITE; GLYCOSYLATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOMEOSTASIS; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; STOMACH MUCOSA; TANDEM MASS SPECTROMETRY;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; BINDING SITES; CARBOHYDRATE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE SUSCEPTIBILITY; FEMALE; GASTRIC MUCINS; GASTRIC MUCOSA; GLYCOSYLATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LEWIS BLOOD-GROUP SYSTEM; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES; PROTEIN BINDING;

HELICOBACTER PYLORI;

EID: 84864445615     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cws072     Document Type: Article

References (43)

1. Allen A, Flemstrom G, Garner A, Kivilaakso E. 1993. Gastroduodenal mucosal protection. Physiol Rev. 734:823-857.
2. Alm RA, Ling LS, Moir DT, King BL, Brown ED, Doig PC, Smith DR, Noonan B, Guild BC, deJonge BL, et al. 1999. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 3976715:176-180.
3. Aspholm-Hurtig M, Dailide G, Lahmann M, Kalia A, Ilver D, Roche N, Vikstrom S, Sjostrom R, Linden S, Backstrom A, et al. 2004. Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science 3055683:519-522.
4. Babu SD, Jayanthi V, Devaraj N, Reis CA, Devaraj H. 2006. Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium. Mol Cancer. 5:10.
5. Blaser MJ, Chyou PH, Nomura A. 1995. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res. 553:562-565.
6. Boren T, Falk P, Roth KA, Larson G, Normark S. 1993. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 2625141:1892-1895.
7. Buisine MP, Devisme L, Maunoury V, Deschodt E, Gosselin B, Copin MC, Aubert JP, Porchet N. 2000. Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands. I. Stomach. A relationship to gastric carcinoma. J Histochem Cytochem. 4812:1657-1666.
8. Carlson DM. 1968. Structures and immunochemical properties of oligosaccharides isolated from pig submaxillary mucins. J Biol Chem. 2433:616-626.
9. Clarke CA, Cowan WK, Edwards JW, Howel-Evans AW, Mc CR, Woodrow JC, Sheppard PM. 1955. The relationship of the ABO blood groups to duodenal and gastric ulceration. Br Med J. 2494:643-646.
10. Corfield AP, Wagner SA, Clamp JR, Kriaris MS, Hoskins LC. 1992. Mucin degradation in the human colon: production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria. Infect Immun. 6010:3971-3978.
11. Correa P. 1988. A human model of gastric carcinogenesis. Cancer Res. 4813:3554-3560.
12. De Bolos C, Garrido M, Real FX. 1995. MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. Gastroenterology 1093:723-734.
13. Dethlefsen L, McFall-Ngai M, Relman DA. 2007. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 4497164:811-818.
14. Domon B, Costello CE. 1988. Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry. Biochemistry 275:1534-1543.
15. Dua VK, Rao BN, Wu SS, Dube VE, Bush CA. 1986. Characterization of the oligosaccharide alditols from ovarian cyst mucin glycoproteins of blood group A using high pressure liquid chromatography (HPLC) and high field 1H NMR spectroscopy. J Biol Chem. 2614:1599-1608.
16. Hanisch FG, Chai W, Rosankiewicz JR, Lawson AM, Stoll MS, Feizi T. 1993. Core-typing of O-linked glycans from human gastric mucins. Lack of evidence for the occurrence of the core sequence Gal1-6GalNAc. Eur J Biochem. 2172:645-655.
17. Hollingsworth MA, Swanson BJ. 2004. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer. 41:45-60.
18. Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, Berg DE, Covacci A, Engstrand L, Boren T. 1998. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 2795349:373-377.
19. Issa S, Moran AP, Ustinov SN, Lin JH, Ligtenberg AJ, Karlsson NG. 2010. O-linked oligosaccharides from salivary agglutinin: Helicobacter pylori binding sialyl-Lewis x and Lewis b are terminating moieties on hyperfucosylated oligo-N-acetyllactosamine. Glycobiology 208:1046-1057.
20. Jiang C, McClure SF, Stoddart RW, McClure J. 2004. Lectin histochemistry of normal human gastric mucosa. Glycoconj J. 206:367-374.
21. Karlsson NG, Karlsson H, Hansson GC. 1996. Sulphated mucin oligosaccharides from porcine small intestine analysed by four-sector tandem mass spectrometry. J Mass Spectrom. 315:560-572.
22. Kawakubo M, Ito Y, Okimura Y, Kobayashi M, Sakura K, Kasama S, Fukuda MN, Fukuda M, Katsuyama T, Nakayama J. 2004. Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science. 3055686:1003-1006.
23. Koerner TA, Prestegard JH, Yu RK. 1987. Oligosaccharide structure by twodimensional proton nuclear magnetic resonance spectroscopy. Methods Enzymol. 138:38-59.
24. Lee H, Wang P, Hoshino H, Ito Y, Kobayashi M, Nakayama J, Seeberger PH, Fukuda M. 2008. α1,4GlcNAc-capped mucin-type O-glycan inhibits cholesterol α-glucosyltransferase from Helicobacter pylori and suppresses H. pylori growth. Glycobiology. 187:549-558.
25. Lesuffleur T, Roche F, Hill AS, Lacasa M, Fox M, Swallow DM, Zweibaum A, Real FX. 1995. Characterization of a mucin cDNA clone isolated from HT-29 mucus-secreting cells. The 3′ end of MUC5AC? J Biol Chem. 2723:13665-13673.
26. Linden SK, Sutton P, Karlsson NG, Korolik V, McGuckin MA. 2008. Mucins in the mucosal barrier to infection. Mucosal Immunol. 13:183-197.
27. Machado JC, Nogueira AM, Carneiro F, Reis CA, Sobrinho-Simoes M. 2000. Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol. 1904:437-443.
28. Maes E, Bonachera F, Strecker G, Guerardel Y. 2009. SOACS index: an easy NMR-based query for glycan retrieval. Carbohydr Res. 3443:322-330.
29. Marshall BJ, Warren Jr. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1839:1311-1315.
30. McGuckin MA, Linden SK, Sutton P, Florin TH. 2011. Mucin dynamics and enteric pathogens. Nat Rev Microbiol. 94:265-278.
31. Mollicone R, Bara J, Le Pendu J, Oriol R. 1985. Immunohistologic pattern of type 1 (Lea, Leb) and type 2 (X, Y, H) blood group-related antigens in the human pyloric and duodenal mucosae. Lab Invest. 532:219-227.
32. Nakamura N, Ota H, Katsuyama T, Akamatsu T, Ishihara K, Kurihara M, Hotta K. 1998. Histochemical reactivity of normal, metaplastic, and neoplastic tissues to alpha-linked N-acetylglucosamine residue-specific monoclonal antibody HIK1083. J Histochem Cytochem. 467:793-801.
33. Nordman H, Davies JR, Lindell G, de Bolos C, Real F, Carlstedt I. 2002. Gastric MUC5AC and MUC6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution. Biochem J. 364(Pt 1):191-200.
34. Oberhuber G, Kranz A, Dejaco C, Dragosics B, Mosberger I, Mayr W, Radaszkiewicz T. 1997. Blood groups Lewis(b) and ABH expression in gastric mucosa: lack of inter-relation with Helicobacter pylori colonisation and occurrence of gastric MALT lymphoma. Gut. 411:37-42.
35. Robbe C, Capon C, Coddeville B, Michalski JC. 2004. Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract. Biochem J. 384(Pt 2):307-316.
36. Robbe C, Michalski JC, Capon C. 2006. Structural determination of O-glycans by tandem mass spectrometry. Methods Mol Biol. 347:109-123.
37. Sheehan JK, Brazeau C, Kutay S, Pigeon H, Kirkham S, Howard M, Thornton DJ. 2000. Physical characterization of the MUC5AC mucin: a highly oligomeric glycoprotein whether isolated from cell culture or in vivo from respiratory mucous secretions. Biochem J. 347(Pt 1):37-44.
38. Thornton DJ, Holmes DF, Sheehan JK, Carlstedt I. 1989. Quantitation of mucus glycoproteins blotted onto nitrocellulose membranes. Anal Biochem. 1821:160-164.
39. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, et al. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 3886642:539-547.
40. Tzouvelekis LS, Mentis AF, Makris AM, Spiliadis C, Blackwell C, Weir DM. 1991. In vitro binding of Helicobacter pylori to human gastric mucin. Infect Immun. 5911:4252-4254.
41. Van Beurden-Lamers WM, Spee-Brand R, Dekker J, Strous GJ. 1989. Sulphation causes heterogeneity of gastric mucins. Biochim Biophys Acta. 9903:232-239.
42. Van den Brink GR, Tytgat KM, Van der Hulst RW, Van der Loos CM, Einerhand AW, Buller HA, Dekker J. 2000. H pylori colocalises with MUC5AC in the human stomach. Gut. 465:601-607.
43. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG. 1993. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 3428871:575-577.